KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $408.4 million.

  • Medpace Holdings' Accumulated Expenses rose 3267.47% to $408.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $408.4 million, marking a year-over-year increase of 3267.47%. This contributed to the annual value of $408.4 million for FY2025, which is 3267.47% up from last year.
  • Medpace Holdings' Accumulated Expenses amounted to $408.4 million in Q4 2025, which was up 3267.47% from $368.7 million recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Accumulated Expenses registered a high of $408.4 million during Q4 2025, and its lowest value of $123.6 million during Q1 2021.
  • Moreover, its 5-year median value for Accumulated Expenses was $248.4 million (2023), whereas its average is $244.3 million.
  • In the last 5 years, Medpace Holdings' Accumulated Expenses soared by 4166.78% in 2021 and then soared by 506.76% in 2024.
  • Over the past 5 years, Medpace Holdings' Accumulated Expenses (Quarter) stood at $159.3 million in 2021, then skyrocketed by 31.92% to $210.1 million in 2022, then skyrocketed by 39.42% to $293.0 million in 2023, then increased by 5.07% to $307.8 million in 2024, then skyrocketed by 32.67% to $408.4 million in 2025.
  • Its Accumulated Expenses stands at $408.4 million for Q4 2025, versus $368.7 million for Q3 2025 and $323.5 million for Q2 2025.